Relevance of Veinous Lactates to Predict Postoperative Complications in Children 0-1 Years

Launched by HÔPITAL ARMAND TROUSSEAU · Mar 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how the level of a substance called veinous lactate in the blood at the end of surgery might help predict complications that could happen after surgery in very young children, specifically infants aged 0 to 1 year. The researchers believe that higher levels of lactate could mean a higher chance of problems after surgery, just like what has been seen in adults. To participate, infants need to be having surgery that requires general anesthesia, and they must be under 1 year old. However, infants who are having certain types of surgeries, like heart surgery or procedures that don't require staying overnight, cannot take part in this study.

If your child is eligible and joins the trial, blood samples will be taken from them as part of the routine process before they wake up from anesthesia. The goal is to see if measuring lactate levels can help doctors better understand and manage any complications that may arise after surgery. This research has the potential to improve care for infants undergoing surgery in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • surgery under general anesthesia
• • age \< 1 year
• Exclusion Criteria:
• • ambulatory surgery
• • cardiac surgery
• • preoperative hemodynamic instability
• • Weight \< 2 kg